# Title

 Food and Drugs. PART 500â€”GENERAL


# ID

 CFR-2018-title21-vol6.Pt. 500


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Money       | [(100.0, 'GBP')]                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Constraints | ['least', 'before', 'within', 'equal to', 'not to exceed', 'less than or equal to', 'maximum', 'after', 'minimum', 'exceed']                                                                                                                                                                                                                                                                                                                       |
| Condition   | ['until', 'unless', 'where', 'subject to', 'provided that', 'when', 'if']                                                                                                                                                                                                                                                                                                                                                                          |
| Entities    | ['Methylene', 'United States', 'Phenoclor', 'Hexachlorophene', 'Target', 'New Animal Drug Evaluation', 'Anthelmintic', 'Usual', 'Gentian', 'Colphen', 'France', 'Test', 'Residue', 'Kanaclor', 'Limit', 'Epinephrine', 'Rockville, MD', 'Inject', 'Emergency', 'Sponsor', 'Scope', 'Regulatory', 'Food', 'Heinz', 'Propylene', 'Adequate', 'Sm', 'Japan', 'Marker', 'Food and Drugs', 'Threshold', 'Rm', 'Action', 'Germany', 'New', 'Industrial'] |
| Date        | ['1977-09-29', '1978-04-10', '1975-02-25', '2011-09-26']                                                                                                                                                                                                                                                                                                                                                                                           |


# Structured Analysis With Context

 


## Money

| Money          | Context                                                                                                |
|:---------------|:-------------------------------------------------------------------------------------------------------|
| (100.0, 'GBP') | Usual Dosage: Cattle, horses, sheep, and swine&#8212;1 cubic centimeter per 100 pounds of body weight. |


## Constraints

| Constraints           | Context                                                                                                         |
|:----------------------|:----------------------------------------------------------------------------------------------------------------|
| within                | delayed-release drugs, are regarded as new animal drugs within the meaning of section 201(v) of the Federal     |
| within                | into interstate commerce are deemed to be adulterated within the meaning of section 501(a)(5) of the act        |
| within                | are neither safe nor generally recognized as effective within the meaning of section 201(v) of the act          |
| before                | (3) On or  before  Sept.                                                                                        |
| before                | On or  before  Sept.                                                                                            |
| least                 | replacements must be adequately determined so that the least  potentially hazardous replacement should be used. |
| maximum               | be given to (a) its toxicity; (b) the maximum quantity that could be spilled onto a given                       |
| before                | be spilled onto a given quantity of food before it would be noticed, taking into account its                    |
| not to exceed         | of a product preservative system at a level not to exceed 0.1 percent; that there is no information on          |
| after                 | submitted pursuant to paragraph (c) of this section. after                                                      |
| within                | interstate commerce shall be deemed to be adulterated within the meaning of section 501(a)(5) of the act        |
| within                | causes such a product to be a drug within the meaning of section 201(g) of the Federal                          |
| within                | such product and causes it to be misbranded within the meaning of section 502(a) and (f)(1) of                  |
| within                | causes such a product to be a drug within  the meaning of section 201(g) of the act.                            |
| within                | such product and causes it to be misbranded within the meaning of section 502(a) and (f)(1) of                  |
| maximum               | as meeting the conditions with respect to the maximum quantity of drug per dosage unit if they                  |
| maximum               | as meeting the conditions with respect to the maximum quantity of drug per dosage unit if they                  |
| after                 | These symptoms may appear shortly  after  injection of a bacterin, vaccine, or antibiotic.                      |
| after                 | period or milk discard time means the time after cessation of administration of the sponsored compound at       |
| equal to              | tissue when the residue of carcinogenic concern is equal to  Sm.                                                |
| maximum               | a specific edible tissue that corresponds to a maximum lifetime risk of cancer in the test animals              |
| maximum               | diet of test animals that corresponds to a maximum lifetime risk of cancer in the test animals                  |
| maximum               | residue of carcinogenic concern that corresponds to a maximum lifetime risk to the test animal of 1             |
| maximum               | in a specific edible tissue corresponding to a maximum lifetime risk of cancer in test animals of               |
| less than or equal to | The LOD must be  less than or equal to  Rm.                                                                     |
| exceed                | that the residue of carcinogenic concern does not exceed Sm in each of the edible tissues and,                  |
| exceed                | that the residue of carcinogenic concern does not exceed Sm in each of the edible tissues and,                  |
| minimum               | marker residue in the target tissue at a minimum  concentration corresponding to the Rm.                        |


## Condition

| Condition     | Context                                                                                                                                 |
|:--------------|:----------------------------------------------------------------------------------------------------------------------------------------|
| subject to    | not in compliance with this section will be subject to  regulatory proceedings.                                                         |
| if            | a possibility of unsafe overdosage or ineffective dosage if such products are improperly made and the active                            |
| subject to    | meaning of section 501(a)(5) of the act and subject to regulatory action, unless such animal drug is the                                |
| unless        | of the act and subject to regulatory action, unless such animal drug is the subject of an                                               |
| until         | and that these release characteristics will be maintained until  the expiration date of the drug.                                       |
| when          | blue cause Heinz body hemolytic anemia in cats when  used according to label directions.                                                |
| subject to    | misbranded under section 502(a) of the act and subject to  regulatory action as of April 10, 1978.                                      |
| until         | grounds for continued marketing of this drug substance until  such application is approved.                                             |
| subject to    | in animal feed and is a food additive subject to section 409 of the Federal Food, Drug, and                                             |
| unless        | Federal Food, Drug, and Cosmetic Act (the act), unless it is intended for use as a new                                                  |
| subject to    | in animal feed and is a food additive subject to section 409 of the Federal Food, Drug, and                                             |
| subject to    | food animals and is a new animal drug subject to section 512 of the Federal Food, Drug, and                                             |
| subject to    | If the animal drug is currently  subject to an approved new animal drug application, each reformulation                                 |
| until         | interim marketing of these animal drugs may continue until  the application has been approved,                                          |
| until         | interim marketing of these animal drugs may continue until  the application has been approved,                                          |
| until         | interim marketing of these animal drugs may continue until  the application has been approved,                                          |
| unless        | section 501(a)(5) of the act (21 U.S.C. 351(a)(5)) unless such animal drug is the subject of a                                          |
| if            | of new animal drug applications will be initiated if supplemental new animal drug applications have not been                            |
| subject to    | recognized as safe and is a food additive subject to section 409 of the Federal Food, Drug, and                                         |
| when          | drug is not safe and effective for use when used in accordance with labeling direction, or suggesting                                   |
| when          | limited to: (1) Any statement that disclaims liability when the drug is used in accordance with directions                              |
| when          | (2) Any statement that disclaims liability  when the drug is used under &#8220;abnormal&#8221; or &#8220;unforeseeable&#8221;           |
| when          | similar terms may be used in labeling only when appropriately qualified so as to fully inform the                                       |
| when          | similar terms may be used in labeling only when appropriately qualified so as to fully inform the                                       |
| unless        | subject of an approved new animal drug application unless the use of the article under the conditions                                   |
| when          | has offered the opinion that the following drugs when intended for those veterinary uses for which they                                 |
| provided that | from the requirements of &#167;&#8201;201.105(c) of this chapter, provided that  they meet the conditions prescribed in this paragraph. |
| if            | the maximum quantity of drug per dosage unit if they are prepared in a manner that enables                                              |
| if            | be of value in saving lives of animals if it were readily available at the time of                                                      |
| provided that | injection 1:1,000 available for sale without a prescription provided that it is packaged in vials not exceeding 10                      |
| when          | animals of any compound found to induce cancer when ingested by people or animals unless it can                                         |
| unless        | induce cancer when ingested by people or animals unless it can be determined by methods of examination                                  |
| if            | carcinogenicity testing on metabolites of the sponsored compound. if                                                                    |
| if            | of the act for risks other than cancer. if                                                                                              |
| subject to    | sponsored compound and its metabolites should not be subject to this subpart, FDA will continue to consider the                         |
| when          | 201 of the act apply to those terms when  used in this subpart.                                                                         |
| when          | of the marker residue in the target tissue when the residue of carcinogenic concern is equal to                                         |
| where         | monitor for residues in the target animals, including, where  appropriate, milk or eggs.                                                |
| if            | the remainder of the requirements of this subpart. if                                                                                   |
| when          | that the provisions of this subpart are satisfied when no residue of the compound is detectable (that                                   |
| until         | the depletion of the residue of carcinogenic concern until  its concentration is at or below Sm.                                        |
| until         | depletion of one or more potential marker residues until the concentration of the residue of carcinogenic concern                       |
| when          | to monitor for residues in the edible carcass. when                                                                                     |
| when          | those compounds that FDA determines may induce cancer when ingested by man or animals, i.e., suspect carcinogens,                       |
| when          | FDA determines have been shown to induce cancer when ingested by man or animals, &#167;&#167;&#8201;500.82 through 500.90               |


## Entities

| Entities                   | Context                                                                                                                                                                                                        |
|:---------------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Food                       | Food  and Drugs.                                                                                                                                                                                               |
| Emergency                  | Emergency  permit control.                                                                                                                                                                                     |
| Anthelmintic               | Anthelmintic  drugs for use in animals.                                                                                                                                                                        |
| Food                       | (a) The Commissioner of  Food and Drugs has determined that, in order to                                                                                                                                       |
| New                        | (d)  New animal drug applications for timed-release dosage form animal                                                                                                                                         |
| Methylene                  | Methylene  blue-containing drugs for use in animals.                                                                                                                                                           |
| New                        | (a)  New information requires a re- evaluation of the status                                                                                                                                                   |
| Heinz                      | (ii) The  Heinz body hemolytic anemia reaction to methylene blue has                                                                                                                                           |
| Methylene                  | Methylene blue itself is stepwise demethylated in alkaline solutions                                                                                                                                           |
| New                        | (d)  New animal drug applications required by this regulation pursuant                                                                                                                                         |
| New Animal Drug Evaluation | Center for Veterinary Medicine, Office of  New Animal Drug Evaluation  (HFV-100), 7500 Standish Pl., Rockville, MD 20855.                                                                                      |
| Rockville, MD              | New Animal Drug Evaluation (HFV-100), 7500 Standish Pl., Rockville, MD  20855.                                                                                                                                 |
| Gentian                    | Gentian  violet for use in animal feed.                                                                                                                                                                        |
| Gentian                    | Gentian  violet for animal drug use.                                                                                                                                                                           |
| United States              | a variety of trade names, including: Aroclor ( United States ); Phenoclor (France); Colphen (Germany); and Kanaclor (Japan).                                                                                   |
| Phenoclor                  | variety of trade names, including: Aroclor (United States); Phenoclor  (France); Colphen (Germany); and Kanaclor (Japan).                                                                                      |
| France                     | trade names, including: Aroclor (United States); Phenoclor ( France ); Colphen (Germany); and Kanaclor (Japan).                                                                                                |
| Colphen                    | trade names, including: Aroclor (United States); Phenoclor (France); Colphen  (Germany); and Kanaclor (Japan).                                                                                                 |
| Germany                    | including: Aroclor (United States); Phenoclor (France); Colphen ( Germany ); and Kanaclor (Japan).                                                                                                             |
| Kanaclor                   | Aroclor (United States); Phenoclor (France); Colphen (Germany); and Kanaclor  (Japan).                                                                                                                         |
| Japan                      | States); Phenoclor (France); Colphen (Germany); and Kanaclor ( Japan ).                                                                                                                                        |
| Industrial                 | Industrial uses of PCB's include, or did include in                                                                                                                                                            |
| New                        | (2)  New equipment or machinery for handling or processing feed                                                                                                                                                |
| Hexachlorophene            | Hexachlorophene  in animal drugs.                                                                                                                                                                              |
| Food                       | (a) The Commissioner of  Food and Drugs has determined that there are no                                                                                                                                       |
| Action                     | Action to withdraw approval of new animal drug applications                                                                                                                                                    |
| New                        | (e)  New animal drug applications submitted for animal drugs containing                                                                                                                                        |
| Propylene                  | Propylene  glycol in or on cat food.                                                                                                                                                                           |
| Rockville, MD              | Medicine, Food and Drug Administration, 7500 Standish Pl., Rockville, MD  20855.                                                                                                                               |
| Food                       | Under this proviso, the Commissioner of  Food and Drugs will offer an opinion, upon written                                                                                                                    |
| Food                       | (b) The Commissioner of  Food and Drugs has considered submitted material covering a                                                                                                                           |
| Epinephrine                | Epinephrine injection 1:1,000 in 10-milliliter containers for emergency treatment                                                                                                                              |
| Adequate                   | Adequate directions for use of these antibiotics, bacterins, and                                                                                                                                               |
| Epinephrine                | Epinephrine injection is effective for the treatment of anaphylactoid                                                                                                                                          |
| Food                       | In view of the above, the Commissioner of Food and Drugs has concluded that it is in                                                                                                                           |
| Usual                      | Usual Dosage: Cattle, horses, sheep, and swine&#8212;1 cubic centimeter                                                                                                                                        |
| Inject                     | Inject  subcutaneously&#8221;.                                                                                                                                                                                 |
| Scope                      | Scope  of this subpart.                                                                                                                                                                                        |
| Food and Drugs             | Secretary (a function delegated to the Commissioner of Food and Drugs ) that no residue of that compound will                                                                                                  |
| Rockville, MD              | 1061,  Rockville, MD  20852.                                                                                                                                                                                   |
| Limit                      | Limit of detection (LOD) means the lowest concentration of                                                                                                                                                     |
| Marker                     | Marker residue means the residue selected for assay whose                                                                                                                                                      |
| Regulatory                 | Regulatory method means the aggregate of all experimental procedures                                                                                                                                           |
| Sm                         | the residue of carcinogenic concern is equal to Sm .                                                                                                                                                           |
| Residue                    | Residue means any compound present in edible tissues of                                                                                                                                                        |
| Sponsor                    | Sponsor means the person or organization proposing or holding                                                                                                                                                  |
| Target                     | Target animals means the production class of animals in                                                                                                                                                        |
| Target                     | Target tissue means the edible tissue selected to monitor                                                                                                                                                      |
| Test                       | Test animals means the species selected for use in                                                                                                                                                             |
| Threshold                  | Threshold assessment means FDA's review of data and information                                                                                                                                                |
| Rm                         | LOD must be less than or equal to Rm .                                                                                                                                                                         |
| Marker                     | Marker  residue and target tissue.                                                                                                                                                                             |
| Regulatory                 | Regulatory  method.                                                                                                                                                                                            |
| Rockville, MD              | Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD  20855, 240-276-9120; or go to http://www.fda.gov/AboutFDA/CentersOffices/OfficeofFoods/CVM/CVMFOIAElectronicReadingRoom/default.htm. |
| Rm                         | (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm .                                                                                                                                               |
| Rockville, MD              | 1061,  Rockville, MD 20852, (301) 827-6860, between 9 a.m. and 4                                                                                                                                               |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1975-02-25 | (d) Labeling revisions required for compliance with this section shall be placed into effect by February 25, 1975, following which, any such drugs that are introduced into interstate commerce and not in compliance with this section will be subject to regulatory proceedings.                                                                                                                                                                              |
| 1978-04-10 | (b) Animal drugs that contain methylene blue for oral use in cats or dogs and not the subject of an approved new animal drug application (NADA) are deemed to be adulterated under the provisions of section 501(a) (5) and/or (6) and/or misbranded under section 502(a) of the act and subject to regulatory action as of April 10, 1978.                                                                                                                     |
| 1977-09-29 | (c) Any person currently marketing animal drugs that contain hexachlorophene other than as part of a product preservative system for products used on non-food-producing animals at a level not exceeding 0.1 percent shall submit a new animal drug application, supplement an existing application, or reformulate the product by September 29, 1977.                                                                                                         |
| 1977-09-29 | (d) After September 29, 1977, animal drugs that contain hexachlorophene other than for preservative use on non-food-producing animals at a level not exceeding 0.1 percent that are introduced into interstate commerce shall be deemed to be adulterated within the meaning of section 501(a)(5) of the act (21 U.S.C. 351(a)(5)) unless such animal drug is the subject of a new animal drug application submitted pursuant to paragraph (c) of this section. |
| 2011-09-26 | No residues of n-methyl-2-pyrrolidone may be found in the uncooked edible tissues of cattle as determined by a method entitled &#8220;Method of Analysis: N-methyl-2-pyrrolidone,&#8221; September 26, 2011, Center for Veterinary Medicine, Food and Drug Administration, which is incorporated by reference with the approval of the Director of the Federal Register under 5 U.S.C. 522(a) and 1 CFR part 51.                                                |


